About
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Current Value
$369.571 Year Return
Current Value
$369.571 Year Return
Key Details
Market Cap
$144.07B
P/E Ratio
48.62
1Y Stock Return
7.54%
1Y Revenue Growth
10.23%
Dividend Yield
0.90%
Price to Book
7.0
Strategies that include SYK
Double maintains 8 strategies that include SYK - Stryker Corp.
Medium risk
$14,000
0.27%
US Top 500
The textbook passive investment vehicle is generally considered to comprise of 500 of the largest stocks traded within the US. Double's take on this exposes a client to the US stock market in a diversified way without any expense ratio.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
502
High risk
$5,000
0.52%
Growth Stocks
Growth Stocks focuses on companies with strong growth prospects, often found in sectors driving innovation and technological advancement. This ETF invests in companies demonstrating robust revenue and earnings growth, including technology giants, healthcare innovators, and consumer discretionary leaders.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
178
Medium risk
$13,000
2.15%
Health Care Sector
This Strategy focuses on healthcare companies, including pharmaceuticals, biotechnology, healthcare providers, and medical equipment firms. Offering exposure to a sector driven by demographic trends and ongoing medical advancements, it's a strategic choice for investors considering healthcare's long-term growth potential.
Top Sector
Health Care
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
348
Medium risk
$3,000
0.20%
Equal Weighted US Top 500
This index provides equal-weight exposure to the top 500 companies in the US, offering a unique approach compared to traditional market-cap weighted indexes. With an aim to reduce concentration risk by allocating equal amounts to each constituent, it potentially benefits from smaller companies' outperformance.
Top Sector
Industrials
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
502
Low risk
$4,600
0.13%
Medium risk
$33,000
0.26%
US 1000
This strategy tracks a market-cap-weighted index of the 1000-largest US companies. It offers broad exposure to the US equity market, encompassing a diverse range of sectors and industries. By investing in this fund, you gain access to the performance of large and well-established companies within the US economy.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
1001
High risk
$1,500
0.43%
Mega Cap Growth Stocks
Mega Cap Growth Stocks focuses on companies with strong growth prospects, often found in sectors driving innovation and technological advancement. This ETF following strategy invests in mega cap companies demonstrating robust revenue and earnings growth, including technology giants, healthcare innovators, and consumer discretionary leaders.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
69
Stock's related to SYK
The stocks that are correlated to SYK - Stryker Corp. are ISRG, BSX, FR, FI, AVB
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| 56.09% | $181.66B | +32.24% | 0.00% | |
| 55.54% | $147.98B | +46.85% | 0.00% | |
| 46.38% | $7.16B | +5.61% | 3.04% | |
F FIFiserv, Inc. | 46.03% | $126.94B | +43.42% | 0.00% |
| 45.33% | $30.67B | +19.67% | 3.27% | |
| 45.02% | $55.60B | +13.80% | 5.25% | |
P PLDPrologis, Inc. | 44.65% | $104.12B | -10.90% | 3.74% |
M MCOMoody's Corp. | 44.35% | $84.71B | +19.99% | 0.78% |
S SPGIS&P Global, Inc. | 44.13% | $161.31B | +20.52% | 0.74% |
W WELLWelltower, Inc. | 43.92% | $99.26B | +67.72% | 1.68% |
| 43.36% | $22.39B | -13.47% | 0.85% | |
| 42.96% | $228.81B | +18.56% | 1.69% | |
| 42.57% | $19.76B | +29.35% | 3.33% | |
E ECLEcolab, Inc. | 42.52% | $71.95B | +11.13% | 0.97% |
| 42.11% | $6.39B | +28.90% | 3.69% | |
| 41.78% | $499.05B | +14.65% | 0.52% | |
| 41.54% | $1.95B | +35.81% | 0.84% | |
| 41.50% | $8.50B | -1.08% | 4.66% | |
| 41.26% | $140.44B | +28.42% | 1.19% | |
| 41.22% | $27.20B | +16.62% | 3.89% | |
ETF's related to SYK
The ETFs that are correlated to SYK - Stryker Corp. are IHI, IYH, RSPH, JEPI, XLV
Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| 76.29% | $4.62B | 0.4% | |
| 54.79% | $3.15B | 0.39% | |
| 54.40% | $784.50M | 0.4% | |
| 54.13% | $39.27B | 0.35% | |
| 53.94% | $37.76B | 0.09% | |
| 53.68% | $16.17B | 0.09% | |
| 53.52% | $2.65B | 0.084% | |
| 53.17% | $3.89B | 0.41% | |
| 53.13% | $954.59M | 0.62% | |
| 52.66% | $174.19M | 0.35% | |
| 52.39% | $777.58M | 0.5% | |
| 52.37% | $148.70M | 0.5% | |
| 52.13% | $2.90B | 0.08% | |
| 52.09% | $1.34B | 0.16% | |
| 51.77% | $8.53B | 0.54% | |
| 51.74% | $893.86M | 0.11% | |
| 51.60% | $155.36M | 0.5% | |
| 51.51% | $1.87B | 0.25% | |
| 51.30% | $7.39B | 0.09% | |
| 51.28% | $2.00B | 0.33% | |
News
Yahoo
Medical devices, or the medtech sector, are not immune from the reciprocal tariffs announced by Trump yesterday.
Yahoo
VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE: SYK). The business will operate as a standalone company
Yahoo
Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly formed company VB Spine, LLC. “The sale of our spinal implants business enhances our strategic focus, positioning us to meet evolving customer needs and invest where we see the greatest opportunity for innovation and long-term growth,” said Kevin Lo
Yahoo
A Relative Strength Rating upgrade for Stryker shows improving technical performance. Will it continue?
MarketWatch
Stryker Corp. stock underperforms Monday when compared to competitors despite daily gains
Yahoo
We recently published a list of the 10 Best Robotics Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Stryker Corporation (NYSE:SYK) stands against the other robotics stocks held by billionaires. Robotics Market Outlook The robotics industry has grown modestly over the past few years. Robotic […]
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
0% Expense Ratios with TLH
We offer over 50 indexes with zero expense ratios.
Registration will take about 10 seconds